CoChat

Chemokine CXCL1 mediated neutrophil recruitment: Role of glycosaminoglycan interactions

Open access
Sawant, Kirti V., Poluri, Krishna Mohan, Dutta, Amit K., Sepuru, Krishna Mohan, Troshkina, Anna, Garofalo, Roberto P., Rajarathnam, Krishna · 2016 · Scientific Reports

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

The chemokine CXCL1/MGSA plays a pivotal role in the host immune response by recruiting and activating neutrophils for microbial killing at the tissue site. CXCL1 exists reversibly as monomers and dimers, and mediates its function by binding glycosaminoglycans (GAG) and CXCR2 receptor. We recently showed that both monomers and dimers are potent CXCR2 agonists, the dimer is the high-affinity GAG ligand, lysine and arginine residues located in two non-overlapping domains mediate GAG interactions, and there is extensive overlap between GAG and receptor-binding domains. To understand how these structural properties influence in vivo function, we characterized peritoneal neutrophil recruitment of a trapped monomer and trapped dimer and a panel of WT lysine/arginine to alanine mutants. Monomers and dimers were active, but WT was more active indicating synergistic interactions promote recruitment. Mutants from both domains showed reduced GAG heparin binding affinities and reduced neutrophil recruitment, providing compelling evidence that both GAG-binding domains mediate in vivo trafficking. Further, mutant of a residue that is involved in both GAG binding and receptor signaling showed the highest reduction in recruitment. We conclude that GAG interactions and receptor activity of CXCL1 monomers and dimers are fine-tuned to regulate neutrophil trafficking for successful resolution of tissue injury.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep33123

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Neutrophil recruitment profiles of CXCL1 wild type, monomer and dimer at different doses. BALB/c mice were injected intraperitoneally with different doses (0.1, 1 and 10 μg) of the CXCL1 variants. Peritoneal cells were harvested 6 h post-injection and total cells were counted along with differential counting to measure neutrophil levels. The results are expressed as means ± standard error from two independent experiments using 4 animals/group. The levels of neutrophils for both monomer and dimer are compared to WT at each dose and the differences between the variants were compared using ANOVA followed by Tukey’s post hoc analysis. **p < 0.01, ***p < 0.001.
Figure 1 Neutrophil recruitment profiles of CXCL1 wild type, monomer and dimer at different doses. BALB/c mice were injected intraperitoneally with different doses (0.1, 1 and 10 μg) of the CXCL1 variants. Peritoneal cells were harvested 6 h post-injection and total cells were counted along with differential counting to measure neutrophil levels. The results are expressed as means ± standard error from two independent experiments using 4 animals/group. The levels of neutrophils for both monomer and dimer are compared to WT at each dose and the differences between the variants were compared using ANOVA followed by Tukey’s post hoc analysis. **p < 0.01, ***p < 0.001.CC BY · PubMed Central
Figure 2 Protein levels in peritoneal fluid. Peritoneal fluid supernatants from mice were estimated using the BCA assay kit (Pierce). Each data set is representative of two experiments using 4 animals/group. Protein levels for each variant were compared to the PBS control using ANOVA followed by Tukey’s post hoc analysis (p < 0.05). (ns - not significant).
Figure 2 Protein levels in peritoneal fluid. Peritoneal fluid supernatants from mice were estimated using the BCA assay kit (Pierce). Each data set is representative of two experiments using 4 animals/group. Protein levels for each variant were compared to the PBS control using ANOVA followed by Tukey’s post hoc analysis (p < 0.05). (ns - not significant).CC BY · PubMed Central
Figure 3 GAG binding domains in CXCL1. (A) Ribbon representation of the CXCL1 monomer. α-domain and β-domain GAG-binding residues are highlighted in red and blue, respectively. (B) Surface representation of the CXCL1 dimer showing the GAG-binding residues of the α-domain and β-domain are in red and blue, respectively.
Figure 3 GAG binding domains in CXCL1. (A) Ribbon representation of the CXCL1 monomer. α-domain and β-domain GAG-binding residues are highlighted in red and blue, respectively. (B) Surface representation of the CXCL1 dimer showing the GAG-binding residues of the α-domain and β-domain are in red and blue, respectively.CC BY · PubMed Central
Figure 4 Binding affinities of CXCL1 GAG mutants. SPR sensorgrams for (A) CXCL1 WT and (B) K29A mutant passed over immobilized heparin on a BIAcore SA chip. The curves represent the maximum response signal (RU) minus the reference signal (no GAG). Kinetic fits for the raw data are shown in red lines. (C) Steady state Kd analysis. Maximum response units were plotted for each concentration of CXCL1 WT and K29A mutant. (D) Relative binding affinities of the α-domain and β-domain GAG mutants compared to the WT.
Figure 4 Binding affinities of CXCL1 GAG mutants. SPR sensorgrams for (A) CXCL1 WT and (B) K29A mutant passed over immobilized heparin on a BIAcore SA chip. The curves represent the maximum response signal (RU) minus the reference signal (no GAG). Kinetic fits for the raw data are shown in red lines. (C) Steady state Kd analysis. Maximum response units were plotted for each concentration of CXCL1 WT and K29A mutant. (D) Relative binding affinities of the α-domain and β-domain GAG mutants compared to the WT.CC BY · PubMed Central
Figure 5 Receptor activity of GAG mutants. Receptor activity of the CXCL1 mutants was characterized by measuring calcium release in CXCR2 transfected HL60 cells using FLIPR assay. 10 nM of CXCL1 mutants were added to the cells in quadruplicate and raw peak fluorescence was obtained as relative fluorescence units (RFU). Data shown are mean ± SEM of the four measurements, and the graph is a representative of three independent experiments. The calcium release activity for each mutant was compared with the WT using ANOVA followed by Tukey’s post hoc analysis. ***p < 0.001.
Figure 5 Receptor activity of GAG mutants. Receptor activity of the CXCL1 mutants was characterized by measuring calcium release in CXCR2 transfected HL60 cells using FLIPR assay. 10 nM of CXCL1 mutants were added to the cells in quadruplicate and raw peak fluorescence was obtained as relative fluorescence units (RFU). Data shown are mean ± SEM of the four measurements, and the graph is a representative of three independent experiments. The calcium release activity for each mutant was compared with the WT using ANOVA followed by Tukey’s post hoc analysis. ***p < 0.001.CC BY · PubMed Central
Figure 6 Neutrophil recruitment of CXCL1 GAG mutants in the peritoneum. Mice were injected intraperitoneally with 10 μg of each CXCL1 mutant and cells were harvested at 6 h post-injection. Total cells were counted and a differential cell count was done. The results are expressed as means ± standard error from two independent experiments using 4 animals/group. The neutrophil levels for the mutants are compared to the WT using ANOVA followed by Tukey’s post hoc analysis. **p < 0.01, ***p < 0.001.
Figure 6 Neutrophil recruitment of CXCL1 GAG mutants in the peritoneum. Mice were injected intraperitoneally with 10 μg of each CXCL1 mutant and cells were harvested at 6 h post-injection. Total cells were counted and a differential cell count was done. The results are expressed as means ± standard error from two independent experiments using 4 animals/group. The neutrophil levels for the mutants are compared to the WT using ANOVA followed by Tukey’s post hoc analysis. **p < 0.01, ***p < 0.001.CC BY · PubMed Central
Figure 7 Sequences of ELR chemokines. Basic residues of α-domain and β-domain in CXCL1 and other ELR chemokines are highlighted in red and blue, respectively. The BB motif in CXCL1 and the corresponding residues in other chemokines are shaded in yellow.
Figure 7 Sequences of ELR chemokines. Basic residues of α-domain and β-domain in CXCL1 and other ELR chemokines are highlighted in red and blue, respectively. The BB motif in CXCL1 and the corresponding residues in other chemokines are shaded in yellow.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

Items 301–336 of 336

Metadata

Authors
Sawant, K. V., Poluri, K. M., Dutta, A. K., Sepuru, K. M., Troshkina, A., Garofalo, R. P., & Rajarathnam, K.
Affiliations
The University of Texas Medical Branch at Galveston (US)
Corresponding author
Rajarathnam, Krishna
Venue
Scientific Reports
Published
2016-09-14
Volume
6
Issue
1
Pages
33123-33123
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2520597008
Cited by
337
References
37
Citations by year
2026: 26 · 2025: 38 · 2024: 35 · 2023: 44 · 2022: 51 · 2021: 41 · 2020: 37 · 2019: 28 · 2018: 21 · 2017: 16
FWCI
11.69
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Vanderbilt University
  • National Institutes of Health (HL107152)
  • National Heart, Lung, and Blood Institute (P01HL107152)
Topics
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
  • Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
Keywords
CXCL1, neutrophil recruitment, glycosaminoglycan binding, CXCR2, heparin binding, lysine and arginine residues, peritoneal neutrophils, chemokine receptor signaling
MeSH terms
Animals, Cell Movement, Female, Glycosaminoglycans, Mice, Inbred BALB C, Mutation, Neutrophils, Receptors, Interleukin-8B, Mice, Chemokine CXCL1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.